Cargando…

Genetic Alterations in Members of the Proteasome 26S Subunit, AAA-ATPase (PSMC) Gene Family in the Light of Proteasome Inhibitor Resistance in Multiple Myeloma

SIMPLE SUMMARY: In comparison to other neoplasias, Multiple Myeloma is extremely sensitive to changes in protein homeostasis. Therefore, proteasome inhibitors are highly efficient and widely used for this disease. Genetic alterations of the PSMC genes, such as the ones shown in this manuscript, affe...

Descripción completa

Detalles Bibliográficos
Autores principales: Haertle, Larissa, Buenache, Natalia, Cuesta Hernández, Hipólito Nicolás, Simicek, Michal, Snaurova, Renata, Rapado, Inmaculada, Martinez, Nerea, López-Muñoz, Nieves, Sánchez-Pina, José María, Munawar, Umair, Han, Seungbin, Ruiz-Heredia, Yanira, Colmenares, Rafael, Gallardo, Miguel, Sanchez-Beato, Margarita, Piris, Miguel Angel, Samur, Mehmet Kemal, Munshi, Nikhil C., Ayala, Rosa, Kortüm, Klaus Martin, Barrio, Santiago, Martínez-López, Joaquín
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856285/
https://www.ncbi.nlm.nih.gov/pubmed/36672481
http://dx.doi.org/10.3390/cancers15020532
_version_ 1784873582857289728
author Haertle, Larissa
Buenache, Natalia
Cuesta Hernández, Hipólito Nicolás
Simicek, Michal
Snaurova, Renata
Rapado, Inmaculada
Martinez, Nerea
López-Muñoz, Nieves
Sánchez-Pina, José María
Munawar, Umair
Han, Seungbin
Ruiz-Heredia, Yanira
Colmenares, Rafael
Gallardo, Miguel
Sanchez-Beato, Margarita
Piris, Miguel Angel
Samur, Mehmet Kemal
Munshi, Nikhil C.
Ayala, Rosa
Kortüm, Klaus Martin
Barrio, Santiago
Martínez-López, Joaquín
author_facet Haertle, Larissa
Buenache, Natalia
Cuesta Hernández, Hipólito Nicolás
Simicek, Michal
Snaurova, Renata
Rapado, Inmaculada
Martinez, Nerea
López-Muñoz, Nieves
Sánchez-Pina, José María
Munawar, Umair
Han, Seungbin
Ruiz-Heredia, Yanira
Colmenares, Rafael
Gallardo, Miguel
Sanchez-Beato, Margarita
Piris, Miguel Angel
Samur, Mehmet Kemal
Munshi, Nikhil C.
Ayala, Rosa
Kortüm, Klaus Martin
Barrio, Santiago
Martínez-López, Joaquín
author_sort Haertle, Larissa
collection PubMed
description SIMPLE SUMMARY: In comparison to other neoplasias, Multiple Myeloma is extremely sensitive to changes in protein homeostasis. Therefore, proteasome inhibitors are highly efficient and widely used for this disease. Genetic alterations of the PSMC genes, such as the ones shown in this manuscript, affect this Multiple Myeloma vulnerability and, therefore, play a key role in the physiopathogenesis and resistance to proteasome inhibitors. By different modes of action, those alterations are likely to increase the proteolytic capacity of cancer cells. Even though they occur in low frequencies, they can serve as biomarkers to predict and monitor a patient’s response to proteasome inhibitors over time and might be useful to guide therapy. ABSTRACT: For the treatment of Multiple Myeloma, proteasome inhibitors are highly efficient and widely used, but resistance is a major obstacle to successful therapy. Several underlying mechanisms have been proposed but were only reported for a minority of resistant patients. The proteasome is a large and complex machinery. Here, we focus on the AAA ATPases of the 19S proteasome regulator (PSMC1-6) and their implication in PI resistance. As an example of cancer evolution and the acquisition of resistance, we conducted an in-depth analysis of an index patient by applying FISH, WES, and immunoglobulin-rearrangement sequencing in serial samples, starting from MGUS to newly diagnosed Multiple Myeloma to a PI-resistant relapse. The WES analysis uncovered an acquired PSMC2 Y429S mutation at the relapse after intensive bortezomib-containing therapy, which was functionally confirmed to mediate PI resistance. A meta-analysis comprising 1499 newly diagnosed and 447 progressed patients revealed a total of 36 SNVs over all six PSMC genes that were structurally accumulated in regulatory sites for activity such as the ADP/ATP binding pocket. Other alterations impact the interaction between different PSMC subunits or the intrinsic conformation of an individual subunit, consequently affecting the folding and function of the complex. Interestingly, several mutations were clustered in the central channel of the ATPase ring, where the unfolded substrates enter the 20S core. Our results indicate that PSMC SNVs play a role in PI resistance in MM.
format Online
Article
Text
id pubmed-9856285
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-98562852023-01-21 Genetic Alterations in Members of the Proteasome 26S Subunit, AAA-ATPase (PSMC) Gene Family in the Light of Proteasome Inhibitor Resistance in Multiple Myeloma Haertle, Larissa Buenache, Natalia Cuesta Hernández, Hipólito Nicolás Simicek, Michal Snaurova, Renata Rapado, Inmaculada Martinez, Nerea López-Muñoz, Nieves Sánchez-Pina, José María Munawar, Umair Han, Seungbin Ruiz-Heredia, Yanira Colmenares, Rafael Gallardo, Miguel Sanchez-Beato, Margarita Piris, Miguel Angel Samur, Mehmet Kemal Munshi, Nikhil C. Ayala, Rosa Kortüm, Klaus Martin Barrio, Santiago Martínez-López, Joaquín Cancers (Basel) Article SIMPLE SUMMARY: In comparison to other neoplasias, Multiple Myeloma is extremely sensitive to changes in protein homeostasis. Therefore, proteasome inhibitors are highly efficient and widely used for this disease. Genetic alterations of the PSMC genes, such as the ones shown in this manuscript, affect this Multiple Myeloma vulnerability and, therefore, play a key role in the physiopathogenesis and resistance to proteasome inhibitors. By different modes of action, those alterations are likely to increase the proteolytic capacity of cancer cells. Even though they occur in low frequencies, they can serve as biomarkers to predict and monitor a patient’s response to proteasome inhibitors over time and might be useful to guide therapy. ABSTRACT: For the treatment of Multiple Myeloma, proteasome inhibitors are highly efficient and widely used, but resistance is a major obstacle to successful therapy. Several underlying mechanisms have been proposed but were only reported for a minority of resistant patients. The proteasome is a large and complex machinery. Here, we focus on the AAA ATPases of the 19S proteasome regulator (PSMC1-6) and their implication in PI resistance. As an example of cancer evolution and the acquisition of resistance, we conducted an in-depth analysis of an index patient by applying FISH, WES, and immunoglobulin-rearrangement sequencing in serial samples, starting from MGUS to newly diagnosed Multiple Myeloma to a PI-resistant relapse. The WES analysis uncovered an acquired PSMC2 Y429S mutation at the relapse after intensive bortezomib-containing therapy, which was functionally confirmed to mediate PI resistance. A meta-analysis comprising 1499 newly diagnosed and 447 progressed patients revealed a total of 36 SNVs over all six PSMC genes that were structurally accumulated in regulatory sites for activity such as the ADP/ATP binding pocket. Other alterations impact the interaction between different PSMC subunits or the intrinsic conformation of an individual subunit, consequently affecting the folding and function of the complex. Interestingly, several mutations were clustered in the central channel of the ATPase ring, where the unfolded substrates enter the 20S core. Our results indicate that PSMC SNVs play a role in PI resistance in MM. MDPI 2023-01-15 /pmc/articles/PMC9856285/ /pubmed/36672481 http://dx.doi.org/10.3390/cancers15020532 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Haertle, Larissa
Buenache, Natalia
Cuesta Hernández, Hipólito Nicolás
Simicek, Michal
Snaurova, Renata
Rapado, Inmaculada
Martinez, Nerea
López-Muñoz, Nieves
Sánchez-Pina, José María
Munawar, Umair
Han, Seungbin
Ruiz-Heredia, Yanira
Colmenares, Rafael
Gallardo, Miguel
Sanchez-Beato, Margarita
Piris, Miguel Angel
Samur, Mehmet Kemal
Munshi, Nikhil C.
Ayala, Rosa
Kortüm, Klaus Martin
Barrio, Santiago
Martínez-López, Joaquín
Genetic Alterations in Members of the Proteasome 26S Subunit, AAA-ATPase (PSMC) Gene Family in the Light of Proteasome Inhibitor Resistance in Multiple Myeloma
title Genetic Alterations in Members of the Proteasome 26S Subunit, AAA-ATPase (PSMC) Gene Family in the Light of Proteasome Inhibitor Resistance in Multiple Myeloma
title_full Genetic Alterations in Members of the Proteasome 26S Subunit, AAA-ATPase (PSMC) Gene Family in the Light of Proteasome Inhibitor Resistance in Multiple Myeloma
title_fullStr Genetic Alterations in Members of the Proteasome 26S Subunit, AAA-ATPase (PSMC) Gene Family in the Light of Proteasome Inhibitor Resistance in Multiple Myeloma
title_full_unstemmed Genetic Alterations in Members of the Proteasome 26S Subunit, AAA-ATPase (PSMC) Gene Family in the Light of Proteasome Inhibitor Resistance in Multiple Myeloma
title_short Genetic Alterations in Members of the Proteasome 26S Subunit, AAA-ATPase (PSMC) Gene Family in the Light of Proteasome Inhibitor Resistance in Multiple Myeloma
title_sort genetic alterations in members of the proteasome 26s subunit, aaa-atpase (psmc) gene family in the light of proteasome inhibitor resistance in multiple myeloma
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856285/
https://www.ncbi.nlm.nih.gov/pubmed/36672481
http://dx.doi.org/10.3390/cancers15020532
work_keys_str_mv AT haertlelarissa geneticalterationsinmembersoftheproteasome26ssubunitaaaatpasepsmcgenefamilyinthelightofproteasomeinhibitorresistanceinmultiplemyeloma
AT buenachenatalia geneticalterationsinmembersoftheproteasome26ssubunitaaaatpasepsmcgenefamilyinthelightofproteasomeinhibitorresistanceinmultiplemyeloma
AT cuestahernandezhipolitonicolas geneticalterationsinmembersoftheproteasome26ssubunitaaaatpasepsmcgenefamilyinthelightofproteasomeinhibitorresistanceinmultiplemyeloma
AT simicekmichal geneticalterationsinmembersoftheproteasome26ssubunitaaaatpasepsmcgenefamilyinthelightofproteasomeinhibitorresistanceinmultiplemyeloma
AT snaurovarenata geneticalterationsinmembersoftheproteasome26ssubunitaaaatpasepsmcgenefamilyinthelightofproteasomeinhibitorresistanceinmultiplemyeloma
AT rapadoinmaculada geneticalterationsinmembersoftheproteasome26ssubunitaaaatpasepsmcgenefamilyinthelightofproteasomeinhibitorresistanceinmultiplemyeloma
AT martineznerea geneticalterationsinmembersoftheproteasome26ssubunitaaaatpasepsmcgenefamilyinthelightofproteasomeinhibitorresistanceinmultiplemyeloma
AT lopezmunoznieves geneticalterationsinmembersoftheproteasome26ssubunitaaaatpasepsmcgenefamilyinthelightofproteasomeinhibitorresistanceinmultiplemyeloma
AT sanchezpinajosemaria geneticalterationsinmembersoftheproteasome26ssubunitaaaatpasepsmcgenefamilyinthelightofproteasomeinhibitorresistanceinmultiplemyeloma
AT munawarumair geneticalterationsinmembersoftheproteasome26ssubunitaaaatpasepsmcgenefamilyinthelightofproteasomeinhibitorresistanceinmultiplemyeloma
AT hanseungbin geneticalterationsinmembersoftheproteasome26ssubunitaaaatpasepsmcgenefamilyinthelightofproteasomeinhibitorresistanceinmultiplemyeloma
AT ruizherediayanira geneticalterationsinmembersoftheproteasome26ssubunitaaaatpasepsmcgenefamilyinthelightofproteasomeinhibitorresistanceinmultiplemyeloma
AT colmenaresrafael geneticalterationsinmembersoftheproteasome26ssubunitaaaatpasepsmcgenefamilyinthelightofproteasomeinhibitorresistanceinmultiplemyeloma
AT gallardomiguel geneticalterationsinmembersoftheproteasome26ssubunitaaaatpasepsmcgenefamilyinthelightofproteasomeinhibitorresistanceinmultiplemyeloma
AT sanchezbeatomargarita geneticalterationsinmembersoftheproteasome26ssubunitaaaatpasepsmcgenefamilyinthelightofproteasomeinhibitorresistanceinmultiplemyeloma
AT pirismiguelangel geneticalterationsinmembersoftheproteasome26ssubunitaaaatpasepsmcgenefamilyinthelightofproteasomeinhibitorresistanceinmultiplemyeloma
AT samurmehmetkemal geneticalterationsinmembersoftheproteasome26ssubunitaaaatpasepsmcgenefamilyinthelightofproteasomeinhibitorresistanceinmultiplemyeloma
AT munshinikhilc geneticalterationsinmembersoftheproteasome26ssubunitaaaatpasepsmcgenefamilyinthelightofproteasomeinhibitorresistanceinmultiplemyeloma
AT ayalarosa geneticalterationsinmembersoftheproteasome26ssubunitaaaatpasepsmcgenefamilyinthelightofproteasomeinhibitorresistanceinmultiplemyeloma
AT kortumklausmartin geneticalterationsinmembersoftheproteasome26ssubunitaaaatpasepsmcgenefamilyinthelightofproteasomeinhibitorresistanceinmultiplemyeloma
AT barriosantiago geneticalterationsinmembersoftheproteasome26ssubunitaaaatpasepsmcgenefamilyinthelightofproteasomeinhibitorresistanceinmultiplemyeloma
AT martinezlopezjoaquin geneticalterationsinmembersoftheproteasome26ssubunitaaaatpasepsmcgenefamilyinthelightofproteasomeinhibitorresistanceinmultiplemyeloma